Clinical Trial Update: Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the efficacy, safety, and tolerability of Met DR in adults with Type 2 Diabetes Mellitus over 12 weeks. The study, sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Met DR

Snippet

Sponsor: Elcelyx Therapeutics, Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2015-09-21